Cancer/Tumor Profiling Market by Technique and Application - Global Industry Analysis & Forecast to 2027
Published On : August 2019 Pages : 152 Category: Medical Devices Report Code : HC084639
Cancer/Tumor Profiling Market by Procedure (Proteomics, Epigenetics, Genomics, Metabolomics) Application (Oncological Diagnostics, Personalized Cancer Medicine, Research) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cancer/Tumor Profiling Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Cancer or tumor profiling helps with individualizing malignant growth treatment by giving valuable data at the sub-atomic or hereditary level. This causes restorative professionals to plan a suitable treatment for patients experiencing cancer. This method helps with examining a cancer cells in patients and in investigating the hereditary attributes and unique biomarkers.
Drivers and Restraints
Fast ascent in weight of cancer and increment in subsidizing from government for formulating disease diagnosing strategies increase the market development. Nonetheless, high financial speculations for the improvement of biomarkers and shortage of talented oncologists and related experts control the market development.
Regional Insights
North America is assessed to represent the biggest share as far as income inferable from presence of significant players and quick advances in technology.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Qiagen N.V.
- HTG Molecular Diagnostics, Inc.
- Caris Life Sciences
- NanostringTechologies
- Ribomed Biotechnologies, Inc.
- Illumina, Inc.
- Neogenomics Laboratories Inc.
- Genomic Health Inc
- Helomics Corporation
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cancer/Tumor Profiling Market, By Technique, Estimates and Forecast, 2017-2027 ($Million)
o Proteomics
o Epigenetics
o Genomics
o Metabolomics
· Cancer/Tumor Profiling Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Oncological Diagnostics
o Personalized Cancer Medicine
o Research
· Cancer/Tumor Profiling Market, By Key Players
o Qiagen N.V.
o HTG Molecular Diagnostics, Inc.
o Caris Life Sciences
o NanostringTechologies
o Ribomed Biotechnologies, Inc.
o Illumina, Inc.
o Neogenomics Laboratories Inc.
o Genomic Health Inc
o Helomics Corporation
o Oxford Gene Technology
· Cancer/Tumor Profiling Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cancer/Tumor Profiling Market, By Country
o U.S. Cancer/Tumor Profiling Market
o Canada Cancer/Tumor Profiling Market
o Mexico Cancer/Tumor Profiling Market
o Europe
§ Europe Cancer/Tumor Profiling Market, By Country
o Germany Cancer/Tumor Profiling Market
o UK Cancer/Tumor Profiling Market
o France Cancer/Tumor Profiling Market
o Russia Cancer/Tumor Profiling Market
o Italy Cancer/Tumor Profiling Market
o Rest of Europe Cancer/Tumor Profiling Market
o Asia-Pacific
§ Asia-Pacific Cancer/Tumor Profiling Market, By Country
o China Cancer/Tumor Profiling Market
o Japan Cancer/Tumor Profiling Market
o South Korea Cancer/Tumor Profiling Market
o India Cancer/Tumor Profiling Market
o Southeast Asia Cancer/Tumor Profiling Market
o Rest of Asia-Pacific Cancer/Tumor Profiling Market
o South America
§ South America Cancer/Tumor Profiling Market
o Brazil Cancer/Tumor Profiling Market
o Argentina Cancer/Tumor Profiling Market
o Columbia Cancer/Tumor Profiling Market
o Rest of South America Cancer/Tumor Profiling Market
o Middle East and Africa
§ Middle East and Africa Cancer/Tumor Profiling Market
o Saudi Arabia Cancer/Tumor Profiling Market
o UAE Cancer/Tumor Profiling Market
o Egypt Cancer/Tumor Profiling Market
o Nigeria Cancer/Tumor Profiling Market
o South Africa Cancer/Tumor Profiling Market
o Rest of MEA Cancer/Tumor Profiling Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Or Tumor Profiling Market, By Technique
5.1. Introduction
5.2. Global Cancer Or Tumor Profiling Revenue and Market Share by Technique (2017-2027)
5.2.1. Global Cancer Or Tumor Profiling Revenue and Revenue Share by Technique (2017-2027)
5.3. Proteomics
5.3.1. Global Proteomics Revenue and Growth Rate (2017-2027)
5.4. Epigenetics
5.4.1. Global Epigenetics Revenue and Growth Rate (2017-2027)
5.5. Genomics
5.5.1. Global Genomics Revenue and Growth Rate (2017-2027)
5.6. Metabolomics
5.6.1. Global Metabolomics Revenue and Growth Rate (2017-2027)
6. Cancer Or Tumor Profiling Market, By Application
6.1. Introduction
6.2. Global Cancer Or Tumor Profiling Revenue and Market Share by Application (2017-2027)
6.2.1. Global Cancer Or Tumor Profiling Revenue and Revenue Share by Application (2017-2027)
6.3. Oncological Diagnostics
6.3.1. Global Oncological Diagnostics Revenue and Growth Rate (2017-2027)
6.4. Personalized Cancer Medicine
6.4.1. Global Personalized Cancer Medicine Revenue and Growth Rate (2017-2027)
6.5. Research
6.5.1. Global Research Revenue and Growth Rate (2017-2027)
7. Cancer Or Tumor Profiling Market, By Region
7.1. Introduction
7.2. Global Cancer Or Tumor Profiling Revenue and Market Share by Regions
7.2.1. Global Cancer Or Tumor Profiling Revenue by Regions (2017-2027)
7.3. North America Cancer Or Tumor Profiling by Countries
7.3.1. North America Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2027)
7.3.2. North America Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Cancer Or Tumor Profiling by Countries
7.4.1. Europe Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2027)
7.4.2. Europe Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Cancer Or Tumor Profiling by Countries
7.5.1. Asia-Pacific Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Cancer Or Tumor Profiling by Countries
7.6.1. South America Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2027)
7.6.2. South America Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Cancer Or Tumor Profiling by Countries
7.7.1. Middle East and Africa Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Qiagen N.V.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. HTG Molecular Diagnostics, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Caris Life Sciences
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. NanostringTechologies
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Ribomed Biotechnologies, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Illumina, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Neogenomics Laboratories Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Genomic Health Inc
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Helomics Corporation
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Oxford Gene Technology
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.1. Global Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Cancer Or Tumor Profiling Market Forecast by Regions (2017-2027)
9.2.1. North America Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.1.1. United States Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.1.2. Canada Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.1.3. Mexico Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2. Europe Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.1. Germany Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.2. France Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.3. UK Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.4. Russia Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.5. Italy Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3. Asia-Pacific Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.1. China Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.2. Japan Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.3. Korea Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.4. India Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.4. South America Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.4.1. Brazil Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.4.2. Argentina Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.4.3. Columbia Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.4.4. Rest of South America Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5. Middle East and Africa Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.3. Egypt Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.4. Nigeria Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.5. South Africa Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.6. Turkey Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Cancer Or Tumor Profiling Market Forecast (2017-2027)
9.3. Cancer Or Tumor Profiling Market Forecast by Technique (2017-2027)
9.3.1. Cancer Or Tumor Profiling Forecast by Technique (2017-2027)
9.3.2. Cancer Or Tumor Profiling Market Share Forecast by Technique (2017-2027)
9.4. Cancer Or Tumor Profiling Market Forecast by Application (2017-2027)
9.4.1. Cancer Or Tumor Profiling Forecast by Application (2017-2027)
9.4.2. Cancer Or Tumor Profiling Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Cancer Or Tumor Profiling Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Cancer Or Tumor Profiling Revenue and Revenue Share by Technique (2017-2018)
Figure Global Proteomics Revenue and Growth Rate (2017-2018)
Figure Global Epigenetics Revenue and Growth Rate (2017-2018)
Figure Global Genomics Revenue and Growth Rate (2017-2018)
Figure Global Metabolomics Revenue and Growth Rate (2017-2018)
Table Global Cancer Or Tumor Profiling Revenue and Revenue Share by Application (2017-2018)
Figure Global Oncological Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Personalized Cancer Medicine Revenue and Growth Rate (2017-2018)
Figure Global Research Revenue and Growth Rate (2017-2018)
Table Global Cancer Or Tumor Profiling Revenue by Regions (2017-2018)
Figure North America Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure North America Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2018)
Figure North America Cancer Or Tumor Profiling by Countries (2017-2018)
Figure North America Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2018)
Figure United States Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure United States Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Canada Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Mexico Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Europe Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2018)
Figure Europe Cancer Or Tumor Profiling by Countries (2017-2018)
Figure Europe Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Germany Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Germany Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure France Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure UK Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Russia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Italy Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Rest of Europe Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Or Tumor Profiling by Countries (2017-2018)
Figure Asia-Pacific Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2018)
Figure China Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure China Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Japan Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Korea Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure India Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Southeast Asia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure South America Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2018)
Figure South America Cancer Or Tumor Profiling by Countries (2017-2018)
Figure South America Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Brazil Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Argentina Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Columbia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Rest of South America Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Or Tumor Profiling Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Or Tumor Profiling by Countries (2017-2018)
Figure Middle East and Africa Cancer Or Tumor Profiling Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Saudi Arabia Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Egypt Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Nigeria Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure South Africa Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Turkey Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Or Tumor Profiling Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2017-2018)
Table Qiagen N.V. Cancer Or Tumor Profiling Financial Overview
Table HTG Molecular Diagnostics, Inc. Cancer Or Tumor Profiling Financial Overview
Table Caris Life Sciences Cancer Or Tumor Profiling Financial Overview
Table NanostringTechologies Cancer Or Tumor Profiling Financial Overview
Table Ribomed Biotechnologies, Inc. Cancer Or Tumor Profiling Financial Overview
Table Illumina, Inc. Cancer Or Tumor Profiling Financial Overview
Table Neogenomics Laboratories Inc. Cancer Or Tumor Profiling Financial Overview
Table Genomic Health Inc Cancer Or Tumor Profiling Financial Overview
Table Helomics Corporation Cancer Or Tumor Profiling Financial Overview
Table Oxford Gene Technology Cancer Or Tumor Profiling Financial Overview
Figure Global Cancer Or Tumor Profiling Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Or Tumor Profiling Market Forecast by Regions (2018-2025)
Figure North America Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure United States Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Canada Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Mexico Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Europe Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Germany Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure France Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure UK Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Russia Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Italy Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Rest of Europe Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure China Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Japan Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Korea Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure India Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Southeast Asia Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure South America Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Brazil Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Argentina Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Columbia Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Rest of South America Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Egypt Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Nigeria Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure South Africa Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Turkey Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Or Tumor Profiling Market Forecast (2018-2025)
Figure Global Cancer Or Tumor Profiling Forecast by Technique (2018-2025)
Figure Global Cancer Or Tumor Profiling Market Share Forecast by Technique (2018-2025)
Figure Global Cancer Or Tumor Profiling Forecast by Technique (2018-2025)
Figure Global Cancer Or Tumor Profiling Forecast by Application (2018-2025)
Figure Global Cancer Or Tumor Profiling Market Share Forecast by Application (2018-2025)
Figure Global Cancer Or Tumor Profiling Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|